MAO-A and COMT polymorphisms and gene effects in narcolepsy.

Area of Science:

• Neuroscience
• Genetics
• Sleep Medicine

Background:

• Narcolepsy is strongly associated with HLA-DQB1*0602, but non-HLA genes also contribute to susceptibility.
• The hypocretin/orexin system and monoaminergic systems are implicated in narcolepsy pathophysiology.
• Previous research suggested a genetic link between the monoamine oxidase-A (MAO-A) gene and human narcolepsy.

Purpose of the Study:

• To investigate the association between MAO-A and catechol-O-methyltransferase (COMT) gene polymorphisms and narcolepsy-cataplexy.
• To explore the effects of these genotypes on narcolepsy symptoms and disease severity.

Main Methods:

• Genotyping of MAO-A and COMT polymorphisms in 97 Caucasian patients with narcolepsy-cataplexy.
• Analysis of genotype and allele frequencies for association with narcolepsy.
• Assessment of genotypic effects on clinical symptoms, including sleep latency (MSLT) and REM sleep onsets.

Main Results:

• No significant association was found between MAO-A or COMT gene variants and the presence of narcolepsy.
• A significant sexual dimorphism and effect of COMT genotype on disease severity were observed.
• Women with high COMT activity exhibited faster sleep onset during MSLT compared to men with low COMT activity, with opposite findings in men.
• COMT genotype influenced the occurrence of sleep paralysis and the number of REM sleep onsets during MSLT.

Conclusions:

• This study provides the first genetic evidence for the involvement of dopaminergic and/or noradrenergic systems in human narcolepsy.
• COMT gene variations significantly impact narcolepsy symptom severity, demonstrating a sex-dependent effect.
• Findings align with pharmacological studies in canine narcolepsy, reinforcing the role of these neurotransmitter systems.